Publication | Open Access
Genetic profiling of MYC and BCL2 in diffuse large B-cell lymphoma determines cell-of-origin–specific clinical impact
131
Citations
43
References
2017
Year
Key Points MYC and BCL2 genetic alterations are associated with COO subtype-specific clinical effect in R-CHOP-treated DLBCL.
| Year | Citations | |
|---|---|---|
Page 1
Page 1